Core Viewpoint - Fangda Holdings (01521) experienced a nearly 10% increase in stock price, reaching HKD 1.45, with a trading volume of HKD 1.925 million, following the release of its financial results for the six months ending June 30, 2025 [1] Financial Performance - The company reported revenues of USD 127 million for the period, reflecting a year-on-year decrease of 1.5% [1] - The profit attributable to shareholders was USD 2.927 million, marking a turnaround from a loss in the previous year [1] - Basic earnings per share were USD 0.0014 [1] Quarterly Breakdown - In the first quarter of 2025, the company recorded a loss; however, the financial performance improved in the second quarter due to increased market demand and biopharmaceutical companies outsourcing to reduce costs [1] - The second quarter revenues were approximately USD 69.5 million, representing a year-on-year increase of 7.8%, with a net profit of around USD 3.8 million [1]
方达控股涨近10% 公司盈利能力迎来关键拐点 25Q2财务表现回升